Aim: To evaluate the ability of blood-biomarkers, clinical examination, electrophysiology, or neuroimaging, assessed within 14 days from return of circulation to predict good neurological outcome in children following out- or in-hospital cardiac arrest.
Methods: Medline, EMBASE and Cochrane Trials databases were searched (2010-2023). Sensitivity and false positive rates (FPR) for good neurological outcome (defined as either 'no, mild, moderate disability or minimal change from baseline') in paediatric survivors were calculated for each predictor. Risk of bias was assessed using the QUIPS tool.
Results: Thirty-five studies (2974 children) were included. The presence of any of the following had a FPR <30% for predicting good neurological outcome with moderate (50-75%) or high (>75%) sensitivity: bilateral reactive pupillary light response within 12h; motor component ≥4 on the Glasgow Coma Scale score at 6h; bilateral somatosensory evoked potentials at 24-72h; sleep spindles, and continuous cortical activity on electroencephalography within 24h; or a normal brain MRI at 4-6d. Early (≤12h) normal lactate levels (<2mmol/L) or normal s100b, NSE or MBP levels predicted good neurological outcome with FPR rate <30% and low (<50%) sensitivity. All studies had moderate to high risk of bias with timing of measurement, definition of test, use of multi-modal tests, or outcome assessment heterogeneity.
Conclusions: Clinical examination, electrophysiology, neuroimaging or blood-biomarkers as individual tests can predict good neurological outcome after cardiac arrest in children. However, evidence is often low quality and studies are heterogeneous. Use of a standardised, multimodal, prognostic algorithm should be studied and is likely of added value over single modality testing.
Keywords: Biomarker; Clinical examination; Electroencephalogram; Paediatric cardiac arrest; computed tomography; magnetic resonance imaging; prognosis.
Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.